Name | Number of supported studies | Average coverage | |
---|---|---|---|
erythroblast | 3 studies | 26% ± 7% | |
fibroblast | 3 studies | 29% ± 10% | |
innate lymphoid cell | 3 studies | 29% ± 6% | |
GABAergic neuron | 3 studies | 31% ± 19% | |
glutamatergic neuron | 3 studies | 34% ± 18% | |
natural killer cell | 3 studies | 20% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 33% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 978.24 | 21 / 21 | 100% | 18.11 | 504 / 504 |
uterus | 100% | 1462.47 | 170 / 170 | 100% | 28.84 | 459 / 459 |
esophagus | 100% | 997.12 | 1444 / 1445 | 100% | 15.55 | 183 / 183 |
lung | 100% | 1014.09 | 577 / 578 | 100% | 14.16 | 1154 / 1155 |
breast | 100% | 907.88 | 459 / 459 | 100% | 16.16 | 1113 / 1118 |
stomach | 100% | 678.43 | 359 / 359 | 99% | 12.35 | 284 / 286 |
intestine | 100% | 991.17 | 966 / 966 | 99% | 12.46 | 523 / 527 |
brain | 99% | 901.26 | 2620 / 2642 | 100% | 13.51 | 703 / 705 |
skin | 100% | 1168.53 | 1808 / 1809 | 99% | 16.56 | 466 / 472 |
ovary | 100% | 2007.17 | 180 / 180 | 97% | 10.64 | 419 / 430 |
thymus | 100% | 869.27 | 653 / 653 | 97% | 8.96 | 585 / 605 |
pancreas | 98% | 440.16 | 323 / 328 | 97% | 9.67 | 173 / 178 |
liver | 100% | 715.08 | 226 / 226 | 96% | 10.46 | 388 / 406 |
adrenal gland | 100% | 609.95 | 258 / 258 | 92% | 7.20 | 212 / 230 |
prostate | 100% | 1134.05 | 245 / 245 | 91% | 5.18 | 455 / 502 |
kidney | 100% | 669.80 | 89 / 89 | 87% | 6.98 | 785 / 901 |
adipose | 100% | 1071.38 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.34 | 29 / 29 |
spleen | 100% | 827.43 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.74 | 1 / 1 |
blood vessel | 100% | 903.17 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 569.60 | 842 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 439.43 | 784 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 4.78 | 56 / 80 |
peripheral blood | 60% | 560.86 | 559 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
GO_0033314 | Biological process | mitotic DNA replication checkpoint signaling |
GO_0031297 | Biological process | replication fork processing |
GO_0033260 | Biological process | nuclear DNA replication |
GO_0006260 | Biological process | DNA replication |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0005657 | Cellular component | replication fork |
GO_0030894 | Cellular component | replisome |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | DONSON |
Protein name | DNA replication fork stabilization factor DONSON Protein downstream neighbor of Son (B17) |
Synonyms | C21orf60 |
Description | FUNCTION: Replisome component that maintains genome stability by protecting stalled or damaged replication forks. After the induction of replication stress, required for the stabilization of stalled replication forks, the efficient activation of the intra-S-phase and G/2M cell-cycle checkpoints and the maintenance of genome stability. . |
Accessions | ENST00000444517.5 V9GY84 ENST00000442660.5 H7C1C1 ENST00000303113.10 F8W8A5 ENST00000432378.5 ENST00000457359.5 H7C006 ENST00000440810.1 F8WC22 ENST00000453626.5 ENST00000417871.5 ENST00000437395.5 ENST00000303071.10 [Q9NYP3-1] C9JSP0 C9J4K5 Q9NYP3 F8WD19 H7C304 ENST00000439593.1 H7C1M7 |